Darbepoetin alfa

Janessa Smith, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Darbepoetin alfa is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Anemia due to chronic kidney disease (CKD) in patients on dialysis and those not on dialysis
  • Anemia due to myelosuppressive chemotherapy with a minimum of at least 2 months of planned therapy

NON-FDA APPROVED USES

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: December 4, 2016

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Darbepoetin alfa ID - 545050 A1 - Pham,Paul,Pharm.D. AU - Smith,Janessa,Pharm.D., BCPS Y1 - 2016/12/04/ BT - Johns Hopkins HIV Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545050/all/Darbepoetin_alfa DB - Johns Hopkins Guide DP - Unbound Medicine ER -